Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 532321 | NSE Symbol : ZYDUSLIFE | ISIN : INE010B01027 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

(23-May-25 18:05) Zydus Lifesciences receives USFDA approval for Isotretinoin capsules
(22-May-25 10:18) Zydus Lifesciences to convene AGM
(20-May-25 18:48) Zydus Lifesciences fixes record date for final dividend
(20-May-25 15:17) Board of Zydus Lifesciences recommends final dividend
(20-May-25 14:53) Zydus Lifesciences consolidated net profit declines 0.96% in the March 2025 quarter
(14-May-25 15:28) Zydus Lifesciences receives EIR for its API manufacturing facility at Ambernath
(14-May-25 14:16) Zydus Lifes receives EIR for the Ambernath manufacturing facility
(10-May-25 11:06) Zydus Lifesciences schedules board meeting
(09-May-25 09:21) Zydus Life gets US FDA nod for MS treatment drug Glatiramer Acetate
(30-Apr-25 14:52) Zydus receives USFDA approval for Niacin Extended-Release Tablets

1 2 3 4 5 6 7 8 9 10

Zydus Lifesciences Ltd